These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38145413)
1. Optimizing ambulatory reflux monitoring: current findings and future directions. Dasarathy D; Vaezi M; Patel D Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):13-24. PubMed ID: 38145413 [TBL] [Abstract][Full Text] [Related]
2. AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review. Chen JW; Vela MF; Peterson KA; Carlson DA Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1414-1421.e3. PubMed ID: 37061897 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis of gastroesophageal reflux: an update on current and emerging modalities. Ang D; Lee YY; Clarke JO; Lynch K; Guillaume A; Onyimba F; Kamal A; Gyawali CP Ann N Y Acad Sci; 2020 Dec; 1481(1):154-169. PubMed ID: 32428279 [TBL] [Abstract][Full Text] [Related]
5. Ambulatory reflux monitoring in GERD--which test should be performed and should therapy be stopped? Gawron AJ; Pandolfino JE Curr Gastroenterol Rep; 2013 Apr; 15(4):316. PubMed ID: 23475599 [TBL] [Abstract][Full Text] [Related]
6. Can Impedance-pH Testing on Medications Reliably Identify Patients with GERD as Defined by Pathologic Esophageal Acid Exposure off Medications? Ward MA; Dunst CM; Glasgow ME; Teitelbaum EN; Abdelmoaty WF; Reavis KM; Swanstrӧm LL; DeMeester SR J Gastrointest Surg; 2019 Jul; 23(7):1301-1308. PubMed ID: 30859425 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic options for patients with refractory GERD. Fornari F; Sifrim D Curr Gastroenterol Rep; 2008 Jun; 10(3):283-8. PubMed ID: 18625140 [TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024 [TBL] [Abstract][Full Text] [Related]
9. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo Schey R; Alla SP; Midani D; Parkman HP Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467 [TBL] [Abstract][Full Text] [Related]
10. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives. Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489 [TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance. Hong SK; Vaezi MF Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):1-22, v. PubMed ID: 19232277 [TBL] [Abstract][Full Text] [Related]
12. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor? Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197 [TBL] [Abstract][Full Text] [Related]
13. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [TBL] [Abstract][Full Text] [Related]
14. Endoscopic measurement of gastric pH associates with persistent acid reflux in patients treated with proton-pump inhibitors for gastroesophageal reflux disease. Januszewicz W; Hartley J; Waldock W; Roberts G; Alias B; Hobson A; Wernisch L; di Pietro M United European Gastroenterol J; 2019 Dec; 7(10):1389-1398. PubMed ID: 31807307 [TBL] [Abstract][Full Text] [Related]